Ventres Julian J, Ting Michelle H, Parente Diane M, Rogers Ralph, Norris Ashlyn M, Benitez Gregorio, Shehadeh Fadi, Bobenchik April M, Mylonakis Eleftherios, Chapin Kimberle C, Cunha Cheston B
Department of Pharmacy, The Miriam Hospital, Providence, Rhode Island, USA.
Department of Pharmacy, Banner University Medical Center-Phoenix, Phoenix, Arizona, USA.
Open Forum Infect Dis. 2024 Aug 22;11(9):ofae477. doi: 10.1093/ofid/ofae477. eCollection 2024 Sep.
Traditional blood cultures for gram-negative bacteremia can take up to 72 hours or more to return results, prolonging the duration of empiric broad-spectrum intravenous antibiotics. The Accelerate Pheno system provides rapid identification and susceptibilities for blood cultures in gram-negative bacteremia. Current data on its clinical utility are mixed overall, so the system requires further research.
A multicenter, retrospective quasi-experimental study was conducted comparing the Accelerate Pheno rapid diagnostic system with antimicrobial stewardship intervention and traditional blood cultures alone.
A total of 264 patients with blood cultures with gram-negative bacteria growth were included in the final analysis (102 pre-intervention, 162 post-intervention). The antimicrobial stewardship team made 364 recommendations in 152/162 (93.8%) patients in the post group. Duration of intravenous therapy was shorter ( < .001) for the post-intervention group (median, 4.0 days) compared with the pre-intervention group (median, 7.5 days). Hospital length of stay was also shorter ( < .001) for the post-intervention group (median, 5.1 days) compared with the pre-intervention group (median, 7.0 days). Readmission rates within 30 days were reduced ( = .042) post-intervention (13.0%) compared with pre-intervention (22.6%). In the post-intervention group, a larger proportion of patients were transitioned to oral therapy at any point (126/162, 77.8%) compared with pre-intervention (62/102, 60.8%; < .001).
These results suggest that the Accelerate Pheno system, with active review and intervention by a multidisciplinary antimicrobial stewardship team, is a useful tool in improving both patient-centric and antimicrobial stewardship outcomes.
传统的革兰氏阴性菌血症血培养可能需要长达72小时或更长时间才能得出结果,从而延长了经验性广谱静脉抗生素的使用时间。Accelerate Pheno系统可快速鉴定革兰氏阴性菌血症血培养中的病原体并检测其药敏情况。目前关于其临床效用的数据总体上参差不齐,因此该系统需要进一步研究。
进行了一项多中心、回顾性准实验研究,将Accelerate Pheno快速诊断系统与抗菌药物管理干预措施及单纯传统血培养进行比较。
最终分析纳入了264例血培养有革兰氏阴性菌生长的患者(干预前102例,干预后162例)。抗菌药物管理团队在干预后组的152/162例(93.8%)患者中提出了364条建议。与干预前组(中位数7.5天)相比,干预后组的静脉治疗时间更短(<.001)(中位数4.0天)。与干预前组(中位数7.0天)相比,干预后组的住院时间也更短(<.001)(中位数5.1天)。干预后30天内的再入院率较干预前降低(=.042)(干预后13.0%,干预前22.6%)。在干预后组,与干预前(62/102,60.8%;<.001)相比,更多患者在任何时间点转为口服治疗(126/162,77.8%)。
这些结果表明,在多学科抗菌药物管理团队的积极审查和干预下,Accelerate Pheno系统是改善以患者为中心的结局和抗菌药物管理结局的有用工具。